Literature DB >> 21474540

Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.

Laura Fozzatti1, Changxue Lu, Dong-Wook Kim, Sheue-yann Cheng.   

Abstract

Studies using mice deficient in thyroid hormone receptors (TR) indicate that the two TR isoforms, TRα1 and TRβ1, in addition to mediating overlapping biological activities of the thyroid hormone, T3, also mediate distinct functions. Mice harboring an identical dominant negative mutation (denoted PV) at the C terminus of TRα1 (Thra1(PV) mice) or β1 (Thrb(PV) mice) also exhibit distinct phenotypes. These knockin mutant mice provide an opportunity to understand the molecular basis of isoform-dependent functions in vivo. Here we tested the hypothesis that the distinct functions of TR mutant isoforms are directed by a subset of nuclear regulatory proteins. Tandem-affinity chromatography of HeLa nuclear extracts showed that distinct 33 nuclear proteins including nuclear receptor corepressor (NCoR1) and six other proteins preferentially associated with TRα1PV or TRβ1PV, respectively. These results indicate that recruitment of nuclear regulatory proteins by TR mutants is subtype dependent. The involvement of NCoR1 in mediating the distinct liver phenotype of Thra1(PV) and Thrb(PV) mice was further explored. NCoR1 preferentially interacted with TRα1PV rather than with TRβ1PV. NCoR1 was recruited more avidly to the thyroid hormone response element-bound TRα1PV than to TRβ1PV in the promoter of the CCAAT/enhancer-binding protein α gene to repress its expression in the liver of Thra1(PV) mice, but not in Thrb(PV) mice. This preferential recruitment of NCoR1 by mutant isoforms could contribute, at least in part, to the distinct liver lipid phenotype of these mutant mice. The present study highlights a novel mechanism by which TR isoforms direct their selective functions via preferential recruitment of a subset of nuclear coregulatory proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474540      PMCID: PMC3100599          DOI: 10.1210/me.2010-0474

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  40 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso.

Authors:  Ho-Geun Yoon; Doug W Chan; Albert B Reynolds; Jun Qin; Jiemin Wong
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

Review 3.  Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.

Authors:  Sheue-yann Cheng
Journal:  Trends Endocrinol Metab       Date:  2005 May-Jun       Impact factor: 12.015

Review 4.  The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators.

Authors:  Michael R Stallcup; Jeong Hoon Kim; Catherine Teyssier; Young-Ho Lee; Han Ma; Dagang Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2003-06       Impact factor: 4.292

5.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

Authors:  J W Lee; H S Choi; J Gyuris; R Brent; D D Moore
Journal:  Mol Endocrinol       Date:  1995-02

6.  Brain glucose utilization in mice with a targeted mutation in the thyroid hormone alpha or beta receptor gene.

Authors:  Y Itoh; T Esaki; M Kaneshige; H Suzuki; M Cook; L Sokoloff; S Y Cheng; J Nunez
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation.

Authors:  S Göthe; Z Wang; L Ng; J M Kindblom; A C Barros; C Ohlsson; B Vennström; D Forrest
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

8.  Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.

Authors:  X G Zhu; P McPhie; S Y Cheng
Journal:  Endocrinology       Date:  1997-04       Impact factor: 4.736

9.  Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors.

Authors:  Takanori Esaki; Hideyo Suzuki; Michelle Cook; Kazuaki Shimoji; Sheue-Yann Cheng; Louis Sokoloff; Jacques Nunez
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

10.  Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.

Authors:  C Y Kao; V M Factor; S S Thorgeirsson
Journal:  Biochem Biophys Res Commun       Date:  1996-05-06       Impact factor: 3.575

View more
  10 in total

Review 1.  Nongenomic actions of thyroid hormone.

Authors:  Paul J Davis; Fernando Goglia; Jack L Leonard
Journal:  Nat Rev Endocrinol       Date:  2015-12-15       Impact factor: 43.330

2.  Opening the black box: revealing the molecular basis of thyroid hormone transport.

Authors:  Alexandro J Martagón; Kevin J Philips; Paul Webb
Journal:  Endocrinology       Date:  2013-07       Impact factor: 4.736

3.  A Direct Comparison of Thyroid Hormone Receptor Protein Levels in Mice Provides Unexpected Insights into Thyroid Hormone Action.

Authors:  Svetlana Minakhina; Sanya Bansal; Alice Zhang; Michael Brotherton; Rucha Janodia; Vanessa De Oliveira; Srikanth Tadepalli; Fredric E Wondisford
Journal:  Thyroid       Date:  2020-04-06       Impact factor: 6.568

4.  Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.

Authors:  Xuguang Zhu; Sunmi Park; Woo Kyung Lee; Sheue-Yann Cheng
Journal:  Endocr Relat Cancer       Date:  2019-09       Impact factor: 5.678

5.  Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α.

Authors:  Laura Fozzatti; Dong Wook Kim; Jeong Won Park; Mark C Willingham; Anthony N Hollenberg; Sheue-Yann Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

6.  Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions.

Authors:  Dong Wook Kim; Li Zhao; John Hanover; Mark Willingham; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2012-08-23       Impact factor: 6.166

7.  Gene specific actions of thyroid hormone receptor subtypes.

Authors:  Jean Z Lin; Douglas H Sieglaff; Chaoshen Yuan; Jing Su; Anithachristy S Arumanayagam; Sharareh Firouzbakht; Jaime J Cantu Pompa; Frances Denoto Reynolds; Xiabo Zhou; Aleksandra Cvoro; Paul Webb
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.

Authors:  Laura Fozzatti; Jeong Won Park; Li Zhao; Mark C Willingham; Sheue-Yann Cheng
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

9.  Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors.

Authors:  Xuguang Zhu; Erik Holmsen; Sunmi Park; Mark C Willingham; Jun Qi; Sheue-Yann Cheng
Journal:  Oncotarget       Date:  2018-10-23

10.  Thyroid hormone receptor α mutation causes a severe and thyroxine-resistant skeletal dysplasia in female mice.

Authors:  J H Duncan Bassett; Alan Boyde; Tomas Zikmund; Holly Evans; Peter I Croucher; Xuguang Zhu; Jeong Won Park; Sheue-yann Cheng; Graham R Williams
Journal:  Endocrinology       Date:  2014-06-10       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.